COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.89M USD in the quarter ending March 31, 2026, with 36.12% growth. This brings the company's revenue in the last twelve months to $8.00M, down -10.29% year-over-year. In the year 2025, COSCIENS Biopharma had annual revenue of $7.50M, down -21.79%.

• Revenue (ttm): $8.00M
• Revenue Growth: -10.29%
• P/S Ratio: 0.83
• Revenue / Employee: $285.68K
• Employees: 28
• Market Cap: 9.23M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.50M	-2.09M	-21.79%
Dec 31, 2024	9.59M	2.44M	34.22%
Dec 31, 2023	7.14M	-7.43M	-50.98%
Dec 31, 2022	14.57M	9.31M	177.03%
Dec 31, 2021	5.26M	1.61M	44.03%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error